Filtration leukocytapheresis therapy in rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial

Arthritis and Rheumatism

Volumn 42, Issue 3, 1999, Pages 431-437

  Hidaka, Toshihiko ^a   Suzuki, Kimihiro ^a   Matsuki, Yasunori ^a   Takamizawa Matsumoto, Mitsuyo ^a   Kataharada, Kouji ^a   Ishizuka, Toshiaki ^a   Kawakami, Makoto ^a   Nakamura, Haruo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CENTRIFUGATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTAPHERESIS; DOUBLE BLIND PROCEDURE; FEMALE; FILTRATION; GRAFT VERSUS HOST REACTION; HEMOPERFUSION; HUMAN; LEUKOCYTE; MALE; OUTCOMES RESEARCH; PAIN ASSESSMENT; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ADULT; ARTHRALGIA; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PAIN MEASUREMENT; PLACEBOS;

EID: 0033008517     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:3<431::AID-ANR6>3.0.CO;2-2     Document Type: Article

References (30)

1. Dwosh IL, Giles AR, Ford PM, Pater JL, Anastassiades TP. Plasmapheresis therapy in rheumatoid arthritis: a controlled, double-blind crossover trial. N Engl J Med 1983;308:1124-9.
2. Strober S, Holoshitz J. Mechanisms of immune injury in rheumatoid arthritis: evidence for the involvement of T cells and heatshock proteins. Immunol Rev 1990;118:233-55.
3. Winchester RJ, Winfield JB, Siegal F, Wernet P, Bentwich Z, Kunkel HG. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus: occurrence of interfering cold-reactive antilymphocyte antibodies. J Clin Invest 1974;54:1082-92.
4. Van Boxel JA, Paget SA. Predominantly T-cell infiltrate in rheumatoid synovial membrane. N Engl J Med 1975;293:517-20.
5. Galili U, Rosenthal L, Galili N, Klein E. Activated T cells in the synovial fluid of arthritic patients: characterization and comparison with in vitro activated human and murine T cells in cooperation with monocytes in cytotoxicity. J Immunol 1979;122:878-83.
6. Ueo T, Tanaka S, Tominaga Y, Ogawa H, Sakurami T. The effect of thoracic duct drainage on lymphocyte dynamics and clinical symptoms in patients with rheumatoid arthritis. Arthritis Rheum 1979;22:1405-12.
7. Trentham DE, Belli JA, Anderson RJ, Buckley JA, Goetzl EJ, David JR, et al. Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med 1981;305:976-82.
8. Kotzin BL, Strober S, Engleman EG, Galin A, Hoppe RT, Kansas GS, et al. Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med 1981;305:969-76.
9. Karsh J, Wright DG, Klippel JH, Decker JL, Deisseroth AB, Flye MW. Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis: clinical effects. Arthritis Rheum 1979;22: 1055-9.
10. Karsh J, Klippel JH, Plotz PH, Decker JL, Wright DG, Flye MW. Lymphapheresis in rheumatoid arthritis: a randomized trial. Arthritis Rheum 1981;24:867-73.
11. Moreland LW, Heck LW Jr, Koopman WJ. Biologic agents for treating rheumatoid arthritis: concepts and progress. Arthritis Rheum 1997;40:397-409.
12. Westhovens R, Verwilghen J, Dequeker J. Total lymphoid irradiation in rheumatoid arthritis: a ten-year followup. Arthritis Rheum 1997;40:426-9.
13. Böck M, Krause CH, Wagner M, Heim MU, Braun S, Pachmann U, et al. Transfusion of leukocyte-depleted red cell concentrates and whole blood with a new bedside filter system. Plasma Ther Transfus Technol 1987;8:302-6.
14. Sirchia G, Rebulla P, Parravicini A, Carnelli V, Gianotti GA, Bertolini F. Leukocyte depletion of red cell units at the bedside by transfusion through a new fiber. Transfusion 1987;27:402-5.
15. Kondoh T, Hidaka Y, Katoh H, Inoue N, Saito S. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. Artif Organs 1991;15:180-8.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Suzuki K, Hara M, Harigai M, Ishizuka T, Hirose T, Matsuki Y, et al. Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus. Arthritis Rheum 1991;34:1546-52.
18. Suzuki K, Tanaka N, Matsuki Y, Kawakami M, Kawaguchi Y, Hidaka T, et al. Simplified blood access method for immunoadsorption [letter]. J Clin Apheresis 1992;7:97.
19. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
20. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
21. Abe T, Takeuchi T, Koide J. Assessment of disease activity and quality of life. Medicina 1995;32:2396-401.
22. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
23. Felson DT, Anderson JJ, Lange MLM, Wells G, LaValley MP. Should improvement in rheumatoid arthritis clinical trials be defined as 50% or 70% improvement in core set measures, rather than 20%? [abstract]. Arthritis Rheum 1997;40 Suppl 9:S53.
24. Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S, et al. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990;335:1051-5.
25. Landewé RBM, Goei Thè HS, van Rijthoven AWAM, Breedveld FC, Dijkmans BAC. A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 1994;37:637-43.
26. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat Med 1997;3:189-95.
27. Salmon M, Scheel-Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997;99:439-46.
28. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 1997;186:131-7.
29. Hahn G, Stuhlmuller B, Hain N, Kalden JR, Pfizenmaier K, Burmester GR. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest 1993;91:862-70.
30. Stcinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.